Incidence and predictors of venous thromboembolism in medically ill hospitalized elderly cancer patients: a prospective observational study

2018 ◽  
Vol 27 (7) ◽  
pp. 2507-2515 ◽  
Author(s):  
Jeong-Ok Lee ◽  
Ji Yun Lee ◽  
Eun Ju Chun ◽  
Sang Il Choi ◽  
Jin Won Kim ◽  
...  
Diagnostics ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. 275
Author(s):  
Anca Irina Ristescu ◽  
Georgiana Pintilie ◽  
Mihaela Moscalu ◽  
Daniel Rusu ◽  
Ioana Grigoras

Preoperative cognitive impairment (PCI) in cancer patients includes a broad spectrum of neurocognitive changes produced by complex interplay of patient, tumoural and treatment-related factors. Reduced preoperative cognitive reserve can favour the emergence of postoperative delirium (POD). The study aims to document PCI prevalence and to assess the relationship with POD in elderly cancer patients. The prospective observational study included consecutive patients scheduled for elective surgery; PCI was assessed with Mini-Cog test and defined at a score ≤ 3, POD was screened using Nursing Delirium Screening Scale (Nu-DESC) and defined at a score ≥ 2. Data on education, American Society of Anesthesiologists (ASA) score, preoperative medications, substance use, comorbidities, sensorial deficits, surgery and anaesthesia type, anaesthetic drugs, Mini-Cog score, postoperative pain, Nu-DESC were collected. In total, 131 patients were enrolled, mean age 72.1 ± 5.9 years. PCI prevalence was 51.9% (n = 68). POD prevalence was 19.8% (n = 26), with significantly higher value in PCI patients (27.9% vs. 11.1%, p = 0.016). In multivariate analysis, Mini-Cog score ≤ 3 (OR = 2.6, p = 0.027), clock draw (OR: 2.9, p = 0.013), preoperative renal dysfunction (OR = 2.6, p = 0.012), morphine (OR = 2.7, p = 0.007), metoclopramide (OR = 6.6, p = 0.006), and high pain score (OR = 1.8, p = 0.018) had a significant association with POD development. In this sample of elderly patients, PCI had a high prevalence and predicted the emergence of POD. Incorporating Mini-Cog test into the preoperative evaluation of onco-geriatric patients seems valuable and feasible.


2017 ◽  
Vol 28 ◽  
pp. vi107
Author(s):  
C. Gagliardi ◽  
G. Auletta ◽  
G. Salanitro ◽  
A. Bolamperti ◽  
K. Battistella ◽  
...  

2015 ◽  
Vol 26 ◽  
pp. vii81
Author(s):  
Hiromitsu Kitayama ◽  
Yasushi Tsuji ◽  
Junko Sugiyama ◽  
Tomohiro Kondo ◽  
Michiaki Hirayama

1991 ◽  
Vol 3 (2) ◽  
pp. 333-336 ◽  
Author(s):  
F. Stiefel ◽  
J. Holland

Delirium is the second most common psychiatric diagnosis among hospitalized elderly cancer patients. A variety of factors are known to cause delirium in cancer patients, and the most frequently observed are outlined. History, presence of an altered mental state with identification of the cognitive impairment, and a close watch of mental function will help to differentiate delirium from a normal stress reaction, an adjustment disorder to cancer diagnosis, or early dementia. As in other medically ill patients, antipsychotic drugs are the cornerstone of treatment for delirium not manageable with enviromental manipulation or causal therapy. Haloperidol is the most commonly prescribed drug for delirium in the cancer setting because of its low cardiovascular and anticholinergic effects. Cancer patients who are debilitated require a much lower starting dose than do the physically healthy.


2013 ◽  
Vol 189 (4S) ◽  
Author(s):  
Jessica T. Casey ◽  
Gregory B. Auffenberg ◽  
Laura Mazzenga ◽  
Theresa Sweeney ◽  
Michael A. Dixon ◽  
...  

Life Sciences ◽  
2021 ◽  
pp. 119345
Author(s):  
Alexander Kinnen ◽  
Sven Klaschik ◽  
Claudia Neumann ◽  
Eva-Katharina Egger ◽  
Alexander Mustea ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document